Skip to main content
. Author manuscript; available in PMC: 2024 Mar 22.
Published in final edited form as: Clin Infect Dis. 2021 Dec 6;73(11):1965–1972. doi: 10.1093/cid/ciab570

Table 2.

Reasons for Discontinuing Intravenous Artesunate (IVAS) Prematurely

Reason for Discontinuation 4-dose Regimen
3-dose Regimen
Frequency (N = 14) Frequency (N = 4)
Clinical improvement 4 3

Death 1 1

No reason provided 5 0

Othera 4 0
a

Left against medical advice (1), administration issues (1), error in clinical advice (2).